Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections
The conclusions from this retrospective study further underscore the significant mortality risk and long-term complications associated with catheter-related bloodstream infections (CRBSIs).
- The conclusions from this retrospective study further underscore the significant mortality risk and long-term complications associated with catheter-related bloodstream infections (CRBSIs).
- The data show that of the 51,161 CVC-HD patients studied, approximately 33% of patients initiated on HD with a CVC experience a CRBSI.
- CorMedix remains steadfast in our efforts to obtain marketing authorization and bring DefenCath to patients in 2023.”
The abstract accepted for presentation is included below. - To date, CRBSIs remain a preventable complication of CVC-dependent HD (CVC-HD) with high morbidity and mortality resulting from long-term complications (LTCs).